Status:

TERMINATED

Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)

Lead Sponsor:

Weill Medical College of Cornell University

Conditions:

Posttraumatic Stress Disorder

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This study proposes to evaluate the effects of D-cycloserine (DCS) combined with cognitive-behavioral treatment with exposure therapy in a sample of patients who developed posttraumatic stress disorde...

Detailed Description

Following an initial assessment evaluating eligibility for the study, eligible participants will be randomly assigned to one of two treatment groups: imaginal exposure (IE) plus DCS (100mg) or IE plus...

Eligibility Criteria

Inclusion

  • English-speaking adults
  • Age 18-70
  • Survivor of a variety of traumas (e.g., motor vehicle and accidents, burns and others injuries, combat, World Trade Center attack, etc.)
  • Diagnosed with PTSD
  • In good health. For persons with chronic injuries/conditions related to their accidents, "good health" is defined as the injury being in a state of stabilization and able to attend weekly outpatient sessions.

Exclusion

  • Current organic mental disorder
  • Schizophrenia or symptoms of psychosis/delusions
  • Bipolar disorder
  • Current substance abuse or dependence
  • Active suicidal/homicidal ideation, intent, or plan
  • Use of pacemaker
  • Significant health impairment, including renal disease
  • Taking oral anticoagulant medication, ethionamide (Trecator-SC), isoniazid (INH), or anti-depressant medication
  • Hypersensitivity to cycloserine
  • History of seizures
  • Pregnant or currently trying to conceive, or breastfeeding

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2018

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT00875342

Start Date

May 1 2008

End Date

February 28 2018

Last Update

August 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Weill Cornell Medical College

New York, New York, United States, 10065